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Background: Different models of cortical lesion lead to different effects on plasticity of connections and loss of
function. In opposition to ischemia, cortical lesion made by ablation does not induce significant adaptive plasticity
of corticocortical and corticostriatal projections and leads to functional alterations other than those observed after
ischemia. We have demonstrated sensorimotor recovery after treatment with bone marrow-derived mesenchymal
stem cells (MSCs) or bone marrow mononuclear cells (BMMCs) in a model of focal cortical ischemia. Here, we
extended this analysis evaluating the effect of these cells on sensorimotor recovery after focal cortical ablation,
reproducing the same size and location of previous ischemic lesion.
Findings: Focal cerebral aspiration of the six cortical layers in left frontoparietal cortex was performed in male
Wistar rats. One day later, MSCs or BMMCs were administrated (i.v.) in the ablated animals. Vehicle was
administrated in the control group. Sensorimotor tests were performed before and after injury followed by i.v.
injection. The monitoring of functional recovery was performed weekly during three post-ablation months. The
results showed significant sensorimotor recovery with both treatments, whereas control groups had no recovery.
Moreover, both cell types induced the same level of recovery.
Conclusions: Bone marrow cells showed therapeutic efficacy in a model of brain injury known to promote low
structural plasticity. Thus, the results support the idea of BMMCs as better candidates to treat acute CNS injuries
than MSCs, since they have the same therapeutic potential, but its obtainment for autologous transplantation has
been shown to be faster and easier.
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Several reports have suggested a promising potential of
bone marrow-derived cells to treat brain ischemia [1].
Most studies have used bone marrow-derived mesenchy-
mal stem cells (MSCs) [2]. However, bone marrow
mononuclear cells (BMMCs) has also been shown to be* Correspondence: a.giraldi@ig.com.br
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reproduction in any medium, provided the orbeneficial [3,4]. Moreover, MSCs and BMMCs seem to
have similar potential to promote tissue protection and
functional recovery [5-7].
Studies with sensorimotor cortical ischemia revealed
ischemia-induced structural plasticity [8-10]. Surpris-
ingly, it does not seem to occur when lesion is made by
ablation [8-11]. Functional evaluation showed differences
in the sensorimotor deficits among these two forms of
cortical lesion [12].
We have shown that MSCs and BMMCs induce the
same level of sensorimotor recovery after sensorimotor
cortical ischemia [3,5]. Here, we extended this analysis,
evaluating whether MSCs and BMMCs are able toral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tical ablation, a model known for not being able to in-
duce significant structural plasticity [9,10].
Methods
Adult male Wistar rats (2–4 months old) weighing
250 to 350 g were homogeneously distributed be-
tween experimental groups. Experimental procedures
were approved by the Animal Ethics Committee of our
institution.
Ablation was performed by aspiration, as previously
described [13]. Briefly, after anesthesia with ketamine
hydrochloride (90 mg/kg, i.p.) and xylazine hydrochlor-
ide (10 mg/kg, i.p.), the left frontoparietal cortex (+2 to
−6 mm A.P. from the bregma) was exposed and aspi-
rated with a pipette tip (1 ml) attached to a vacuum
pump. A piece of collagen haemostatic sponge was put
inside the lesion, the skin was sutured, and the animals
were returned after recovery from anesthesia.
Four ablated animals were sacrificed 24 h after abla-
tion. Brains were removed and sectioned in the coronal
plane at 2 mm of thickness. The slices were immersed
for 30 min into 2% 2,3,5-Triphenyltetrazolium chloride
(TTC) solution at 37°C. Digital images were captured
with a camera coupled to a dissecting microscope and a
PC computer.
Bone marrow was harvested aseptically from tibias
and femurs of naive donor rats (2–4 months old), as
previously described [3]. BMMCs were collected
and washed with phosphate-buffered saline (PBS).
After cell counting, they were resuspended in PBS,
and the final concentration was approximately 3 x
107 BMMCs/500 μl.
The protocol for MSCs cultivation used in this work
has been already shown to be effective to obtain
enriched cultures [5]. Briefly, BMMCs were plated in
flasks with DMEM-F12 supplemented with 10% fetal bo-
vine serum (GIBCO BRL). After cells from each flask
had been reached the confluence, they were harvested
and replated in two new flasks for expansion. After the
third replating, cells were harvested and suspended in
PBS, and the final concentration was approximately 3 x
106 MSCs/500 μl.
Twenty four hours after ablation, animals were
anesthetized and injected through the left jugular vein
with MSCs, BMMCs or vehicle (PBS). Experimental
groups are explained in Table 1.Table 1 Experimental groups
Group name Treatment Total number of anima
MSCs group 3 x 106 MSCs in 500 μl 8
BMMCs group 3 x 107 BMMCs in 500 μl 9
Control group 500 μl of PBS 18Blinded investigators performed the analyses to avoid
bias. Animals of all experimental groups were tested one
day before the ablation and at post-ablation day (PAD)
2, and then weekly until PAD 91. The pre-ablation day
was plotted in graphs as PAD 0. Two functional tests
were used, as previously described to assess sensori-
motor function after similar cortical lesion by ischemia
[3,5]. Briefly: 1- Forelimb use asymmetry (cylinder) test:
the trial consisted of placing the animal inside a glass cy-
linder and counting supports in the wall with ipsilateral
(to the lesion), contralateral or with both forelimbs. Ani-
mals with asymmetry score higher than 15 at PAD 0 or
lower than 30 at PAD 2 were discarded. 2- Adhesive re-
moval patch test: a small round adhesive paper (13 mm
diameter) was placed on the inner portion of each wrist
of the animal, and percentage of contralateral preference
relative to the total number of removals was calculated.
Animals with contralateral preference lower than 25% at
PAD 0 or higher than 0% at PAD 2 were discarded.
Repeated measures two-way ANOVA was used for
comparison among groups. Tukey post-hoc test was
used when interaction was significant. When interaction
was not significant, data from all PADs were grouped as
replicates for each animal. Means were plotted for ana-
lyses with t test (two groups) or ANOVA plus Tukey
post-hoc test (three groups). The level of significance
was always set at p < 0.05.
Results
After ablation by aspiration, lesions were restricted to
the removed tissue, without any additional injury
(Figure 1). No animal showed spontaneous rotational
movement and/or abnormal curved posture toward
the lesion side, which indicated the absence of striatal
lesion [14,15]. Ablation mimicked the extension of
cortical lesion that was induced by thermocoagulation
of cortical superficial blood vessels in previous studies
[3,5] (Figure 1). The lesion was effective to promote
loss of sensorimotor function, since all animals
showed clear asymmetry in favor of ipsilateral (unim-
paired) forelimb at PAD 2 in both functional tests
(Figure 2).
Analyses with sensorimotor tests revealed that MSCs
and BMMCs were able to recover function. In Cylinder
Test (Figure 2A), repeated measures two-way ANOVA
revealed no significant interaction (F = 1.03; p = 0.43)




Figure 1 Extension of the lesion induced by ablation. (A)
Sequential images of coronal brain slices of a representative ablated
animal stained with TTC, showing the extension of the lesion in the
anterior-posterior axis. Unilateral ablation removed the six cortical
layers in the dorsal portion of the hemisphere, reaching white
matter. The medial-lateral and anterior-posterior extensions of the
lesion were made to reproduce the same extension of cortical lesion
made by thermocoagulation in previous studies [3]. (B) Images
captured from coronal brain slices of a thermocoagulated ischemic
animal analyzed in a previous study, to illustrate the highly similar
lesion extension of both protocols of injury. Calibration bars = 1 cm.
In (A) and (B), from top to bottom, images were placed from most
anterior to most posterior portion of the lesion. Black (A) and white
(B) arrows point to the place of the lesion induced by the respective
protocol of surgery.
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grouped, and ANOVA showed a significant difference
(F = 9.98; p < 0.001). Comparison between groups
showed significant recovery in MSCs and BMMCs
groups, but no significant difference between them
(Figure 2A). In Adhesive Test, repeated measures two-
way ANOVA revealed a significant interaction (F = 3.93;
p < 0.0001). Post-hoc analysis showed significant recov-
ery of MSCs and BMMCs groups from the PAD 35 on-
wards (Figure 2B). Regarding the comparison between
MSCs and BMMCs groups, post-hoc analysis showed
no significant difference, except at PAD 91, when therecovery induced by BMMCs was significantly higher
(Figure 2B). Together, these results indicate that both
treatments induced the same level of recovery.Discussion
The induction of sensorimotor recovery after cortical ab-
lation by bone marrow-derived MSCs is in agreement to
previous demonstrations of their efficiency to treat CNS
injuries [2]. However, we used the therapeutic window
of 24 h after ablation, a protocol that is only possible
using donor animals. Autologous transplantation of
MSCs is unfeasible after too short time window, since its
enrichment and its expansion are obtained after succes-
sive replating and cultivation for weeks [16]. This delay
hampers transplantation in acute or subacute phases of
CNS lesions, when therapy should be more successful.
BMMCs have been suggested as an alternative for
treatment of acute CNS injuries [1,3,17]. They can be
obtained without cultivation and can be harvested in
1.5-6 h for autologous administration [18,19]. In fact,
BMMCs seem to be only effective when administrated in
the acute/subacute phase of cerebral ischemia [4,5]. We
showed that BMMCs induced sensorimotor recovery
with the same effectiveness of MSCs after cortical abla-
tion. These results are in agreement to other compara-
tive reports, which are scarce but have given support to
the idea of BMMCs as an alternative to MSCs [5-7].
Moreover, we observed that the recovery promoted
by BMMCs was sustained for at least three months,
which is consistent with prior reports from our research
group [5].
The present study deepens demonstration of thera-
peutic potential of bone marrow-derived cells, since we
used a model of cortical lesion not yet used for cell-
based therapies. Cortical ablation mimics a clinical con-
dition of immediate removal of brain tissue, e.g., surgical
removal of brain tumors. It is necessary to verify cell
therapies efficacy in this debilitating condition, although
its occurrence is significantly lower than stroke or trau-
matic brain injury (TBI). Moreover, cortical ablation
model should be attractive for studies about mechanisms
of action of therapies. Ablation differs from the natural
inflammatory process of tissue removal that occurs after
ischemia and TBI. Studies have suggested that inflam-
mation induces lesion-induced structural plasticity,
which is not observed after ablation [8,10]. Increasing
evidences have shown that inflammation triggers a re-
turn to a development-like condition, more permissive
to axon regeneration and lesion-induced structural re-
modeling [8,20]. Thus, our results were of interest, since
we showed sensorimotor recovery induced by cell ther-
apies in a model of lesion that does not cause significant
structural plasticity [8-10].
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migrate to injured tissue and act as a local “factory” of
molecules, promoting angiogenesis, neuroprotection, mod-
ulation of inflammatory response, reduction of glial scarFigure 2 (See legend on next page.)and facilitation of axonal regeneration and plastic rewir-
ing of neuronal connections [2,21,22]. In preliminary
experiments, we have not found systemically administrated
MSCs or BMMCs in the cortical lesion made by ablation
(See figure on previous page.)
Figure 2 MSCs and BMMCs promoted the same level of recovery. (A) Upper graph: sensorimotor function over time in the Cylinder Test. In
all groups, the greater asymmetry was observed at PAD 2. Two-way ANOVA analysis revealed no significant interaction, but significant effect of
the treatment. Thus, MSCs curve and BMMCs group curve were significantly closer to normal state (PAD 0) than the control group curve. Points
in the graph mean mean±SEM. Lower graph: Data from each group was grouped and analyzed by ANOVA followed by a post-hoc analysis,
which showed significant recovery in MSCs and BMMCs groups, but no significant difference between them. Bars mean mean±SEM. * = p < 0.05,
*** = p < 0.001; Tukey. (B) Sensorimotor function over time in the Adhesive Test. Legend in (A) is valid in (B). In all groups, the lower level of
contralateral preference was observed at PID 2. Two-way ANOVA analysis revealed a significant interaction and post-hoc analysis showed
significant recovery in MSCs and BMMCs groups from the PAD 35 onwards. However, significant difference between them was found only at
PAD 91. Points in the graph mean mean±SEM. * represents comparison among MSCs and control groups, # represents the comparison
among BMMCs and control groups and Φ represents the comparison among MSCs and BMMCs groups. (* = p < 0.05; **, ## or ΦΦ = p < 0.01;
*** or ### = p < 0.001; Tukey).
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cells would act in ablation by systemic release of factors.
However, further observations are needed to prove it.
Concluding, we demonstrated that MSCs and BMMCs
are equally able to promote sensorimotor recovery.
Thus, the study supports BMMCs as a cheaper and fas-
ter alternative for the treatment of CNS lesions, ideal for
autologous transplantation in acute and subacute phases.
Furthermore, these cells were able to promote recovery
in a model of cortical lesion known for not being able to
promote significant structural plasticity, a phenomenon
believed to be essential for functional recovery. Thus,
further studies are needed to explain the mechanisms
underlying this recovery, verifying whether these cells
are able to induce structural plasticity after ablation,
and/or whether other mechanisms are lying beneath this
therapeutic effect.
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